Investigating What’s Behind the Rise in ADHD | Four Corners Documentary
Why It Matters
Rising ADHD over‑diagnosis threatens to waste public health resources and leaves truly affected Australians without proper support, while boosting pharma revenues.
Key Takeaways
- •ADHD diagnoses in Australian adults have surged beyond expected prevalence.
- •Prescription rates vary dramatically by suburb, with hotspots in WA and Sydney.
- •Social media and “cosmetic psychopharmacology” may drive self‑diagnosis trends.
- •Diagnostic process lacks objective tests, relying heavily on clinician judgment.
- •Over‑prescribing benefits pharma, while missed cases leave vulnerable patients untreated.
Summary
Four Corners’ documentary investigates why adult ADHD diagnoses are soaring across Australia, revealing a complex mix of clinical, commercial and cultural forces.
National prescription data show a 30% jump in stimulant use between 2020 and 2024, with adult treatment rates reaching 3.4% in Sydney’s inner‑west and over 4% in Fremantle—well above the 2.5‑3% prevalence experts consider realistic. Women under 44 in some suburbs exceed 6%.
The film follows late‑diagnosed patients like Ben Ddale, whose personal story underscores years of mislabeling, and features experts such as Prof. David Cockill, who defines ADHD’s three core symptom clusters, and Prof. Nick Gloier, who warns that diagnosis often hinges on subjective clinician judgment. Social‑media clips on TikTok illustrate how quick, sensational explanations can fuel self‑diagnosis, a phenomenon some call “cosmetic psychopharmacology.”
If unchecked, over‑prescribing inflates pharmaceutical profits while genuine sufferers remain undiagnosed, straining the health system and compromising care quality. The findings call for stricter diagnostic protocols, better public education, and oversight of tele‑health assessment models.
Comments
Want to join the conversation?
Loading comments...